Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Accumulated Expenses (2018 - 2022)

Historic Accumulated Expenses for AdaptHealth (AHCO) over the last 5 years, with Q3 2022 value amounting to $50.5 million.

  • AdaptHealth's Accumulated Expenses rose 2484.01% to $50.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $50.5 million, marking a year-over-year increase of 2484.01%. This contributed to the annual value of $34.4 million for FY2021, which is 2870.25% up from last year.
  • AdaptHealth's Accumulated Expenses amounted to $50.5 million in Q3 2022, which was up 2484.01% from $28.9 million recorded in Q2 2022.
  • AdaptHealth's Accumulated Expenses' 5-year high stood at $50.5 million during Q3 2022, with a 5-year trough of $20609.0 in Q2 2018.
  • For the 5-year period, AdaptHealth's Accumulated Expenses averaged around $20.4 million, with its median value being $17.6 million (2020).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 1068775.29% in 2019, then tumbled by 3266.21% in 2022.
  • Quarter analysis of 5 years shows AdaptHealth's Accumulated Expenses stood at $9.1 million in 2018, then surged by 34.76% to $12.3 million in 2019, then soared by 116.76% to $26.7 million in 2020, then rose by 28.7% to $34.4 million in 2021, then soared by 47.04% to $50.5 million in 2022.
  • Its Accumulated Expenses stands at $50.5 million for Q3 2022, versus $28.9 million for Q2 2022 and $38.9 million for Q1 2022.